Resolian meets the needs of preclinical and clinical programs at any scale
11 Oct 2023
Resolian (formerly Alliance Pharma Inc and Drug Development Solutions Ltd) is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized bioanalytical and analytical sciences solutions. Over 500 experts across the US, UK, and Australia, deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum.
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
About the company
Resolian
Real-world challenges. Your partner for sensible, tailored science. DDS’s Bioanalytical Solutions (BAS) include liquid-chromatography mass spectrometry (LC-MS) and immunoassay bioanalysis, to provide data for pharmacokinetics, immunogenicity, pharmacodynamics and cell-based assays supporting all phases of drug development to GCP and GLP standards. Its Analytical Materials Science solutions (AMS) provides specialist testing of raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control to support CMC (Chemistry Control and Manufacture) analytical testing to GMP (Good Manufacturing Practice) standard.
Related products
Request Quote for All Products
Biopharmaceutical Development Service
ResolianResolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.